Xcenda

@Xcenda

From development through market maturity, we help manufacturers identify, demonstrate, and deliver their brand’s value proposition to healthcare stakeholders.

Vrijeme pridruživanja: studeni 2013.

Tweetovi

Blokirali ste korisnika/cu @Xcenda

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Xcenda

  1. 4. velj

    Xcenda President, Kristine Flemister, speaks with about the importance of technology in expanding market and patient access.

    Poništi
  2. 3. velj

    CMS released its Medicaid block grant proposal, “Healthy Adult Opportunity.” Learn more in the latest edition of Health Policy Weekly:

    Poništi
  3. 30. sij

    The digital revolution has transformed the industry by fundamentally reshaping how pharmaceutical manufacturers operate in portfolio planning, drug development, , brand building and other vitally important areas.

    Poništi
  4. 29. sij

    Looking for input to refine your clinical, , and/or plans? If so, Xcenda is hosting a one-day event in Houston, Texas on April 21, 2020. Learn more about the Managed Care Network (MCN) Forum.

    Poništi
  5. 28. sij

    There's still time to register for today's live webinar at 2:00 PM ET on the recent release of AMCP Format v4.1. Register today:

    Poništi
  6. 27. sij

    The Supreme Court denied to fast track consideration of ACA constitutionality. Learn more in the latest edition of Health Policy Weekly:

    Poništi
  7. 23. sij

    With the recent release of AMCP Format v4.1, what does it mean for the preapproval information exchange between payers and manufacturers? Join us at an live webinar that will give guidance on the early, effective exchange of information.

    Poništi
  8. 21. sij

    Democratic-led states asked the US Supreme Court to take up the case challenging the ACA’s legality. Learn more in the latest edition of Health Policy Weekly:

    Poništi
  9. 16. sij

    With the recent release of AMCP Format v4.1, what does it mean for the preapproval information exchange between payers and manufacturers? Join us at an live webinar that will give guidance on the early, effective exchange of information.

    Poništi
  10. 15. sij

    In 2019, the Maryland General Assembly passed a bill to create a Prescription Drug Affordability Board (HB 768). Learn more in the latest edition of Health Policy Weekly:

    Poništi
  11. 13. sij

    Xcenda and the FormularyDecisions team closely tracked the development recently released AMCP Format Version 4.1 and are available to address questions and provide additional guidance surrounding these updates. Learn more:

    Poništi
  12. 8. sij

    Play an integral role in patient access to important physician-administered therapies. We are looking for Field Reimbursement Managers in several key cities across the US. Learn more:

    Poništi
  13. 27. pro 2019.

    Since 2016, 4 joint assessment agencies have been created across Europe: BeNeLuxAIr, La Valetta, Visegrad, and most recently, FINOSE (Finland, Norway, and Sweden). We take a closer look at FINOSE:

    Poništi
  14. 24. pro 2019.

    Trump Administration announces plan to allow importation. Learn more in the latest edition of Health Policy Weekly:

    Poništi
  15. 19. pro 2019.

    Our article in HTA Quarterly examines the current HTA landscape for advanced therapy medicinal products, such as cell and gene therapies, and the emerging HTA appraisal frameworks. Read more:

    Poništi
  16. 17. pro 2019.

    With million-dollar cures coming to market, what are the current perceptions of value and the role of cost-effectiveness? We explore how and when cost-effectiveness assessments are utilized for making reimbursement and pricing decisions. Read more:

    Poništi
  17. 16. pro 2019.

    The Elijah E. Cummings Lower Drug Costs Now Act (HR 3) passed on a largely party-line vote of 230-192. Learn more in the latest edition of Health Policy Weekly:

    Poništi
  18. proslijedio/la je Tweet
    13. pro 2019.

    The FormularyDecisions platform from was recognized as one of 2019’s most innovative services helping to push healthcare forward. Read more from .

    Poništi
  19. 12. pro 2019.

    We were honored to present at 's 1st Annual HE Innovation Webinar Series. Two of Xcenda's innovations, MetaMap Pro and Virtual Tumor Cases, were featured in a presentation that was named "Audience Favorite." Learn more:

    Poništi
  20. 11. pro 2019.

    The doctor-patient relationship sits at the center of the healthcare system, but when payers insert themselves into the clinical decision-making process, it can diminish the trust and confidence patients have in their providers. Download our recent paper:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·